179 related articles for article (PubMed ID: 12135181)
1. Detection and monitoring of methotrexate-associated lung injury using serum markers KL-6 and SP-D in rheumatoid arthritis.
Miyata M; Sakuma F; Fukaya E; Kobayashi H; Rai T; Saito H; Kasukawa R; Suzuki S
Intern Med; 2002 Jun; 41(6):467-73. PubMed ID: 12135181
[TBL] [Abstract][Full Text] [Related]
2. SP-D as a marker of amiodarone-induced pulmonary toxicity.
Umetani K; Abe M; Kawabata K; Iida T; Kohno I; Sawanobori T; Kugiyama K
Intern Med; 2002 Sep; 41(9):709-12. PubMed ID: 12322797
[TBL] [Abstract][Full Text] [Related]
3. [Interstitial pneumonitis and serum markers (SP-D & KL-6) in collagen vascular diseases].
Sagawa A
Nihon Rinsho Meneki Gakkai Kaishi; 2004 Apr; 27(2):55-63. PubMed ID: 15164926
[No Abstract] [Full Text] [Related]
4. Detection of interstitial pneumonitis in patients with rheumatoid arthritis by measuring circulating levels of KL-6, a human MUC1 mucin.
Oyama T; Kohno N; Yokoyama A; Hirasawa Y; Hiwada K; Oyama H; Okuda Y; Takasugi K
Lung; 1997; 175(6):379-85. PubMed ID: 9330247
[TBL] [Abstract][Full Text] [Related]
5. Serum KL-6 and surfactant proteins A and D in pediatric interstitial lung disease.
Al-Salmi QA; Walter JN; Colasurdo GN; Sockrider MM; Smith EO; Takahashi H; Fan LL
Chest; 2005 Jan; 127(1):403-7. PubMed ID: 15654008
[TBL] [Abstract][Full Text] [Related]
6. Circulating KL-6 levels in patients with drug induced pneumonitis.
Ohnishi H; Yokoyama A; Yasuhara Y; Watanabe A; Naka T; Hamada H; Abe M; Nishimura K; Higaki J; Ikezoe J; Kohno N
Thorax; 2003 Oct; 58(10):872-5. PubMed ID: 14514942
[TBL] [Abstract][Full Text] [Related]
7. [Assessment of serum markers KL-6 and SP-D for interstitial pneumonia associated with connective tissue diseases].
Suematsu E; Miyamura T; Shimada H; Nakao R; Yamamoto M
Ryumachi; 2003 Feb; 43(1):11-8. PubMed ID: 12692985
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders].
Ogawa N; Shimoyama K; Kawabata H; Masaki Y; Wano Y; Sugai S
Ryumachi; 2003 Feb; 43(1):19-28. PubMed ID: 12692986
[TBL] [Abstract][Full Text] [Related]
9. Rheumatoid arthritis associated with methotrexate-induced pneumonitis: improvement with i.v. cyclophosphamide therapy.
Suwa A; Hirakata M; Satoh S; Mimori T; Utsumi K; Inada S
Clin Exp Rheumatol; 1999; 17(3):355-8. PubMed ID: 10410272
[TBL] [Abstract][Full Text] [Related]
10. [Lung injury and serum markers].
Suwabe A
Rinsho Byori; 2002 Nov; 50(11):1061-6. PubMed ID: 12491603
[TBL] [Abstract][Full Text] [Related]
11. [Toxicity of low-dose methotrexate in rheumatoid arthritis--clinical characteristics in patients with MTX-induced pancytopenia and interstitial pneumonitis].
Ohosone Y; Okano Y; Kameda H; Hama N; Matsumura M; Nojima T; Nakamura K; Kuwana M; Ogasawara T; Hirakata M; Yoshida T; Mimori T; Akizuki M; Ikeda Y
Ryumachi; 1997 Feb; 37(1):16-23. PubMed ID: 9128419
[TBL] [Abstract][Full Text] [Related]
12. Interstitial pneumonitis associated with infliximab therapy.
Villeneuve E; St-Pierre A; Haraoui B
J Rheumatol; 2006 Jun; 33(6):1189-93. PubMed ID: 16622902
[TBL] [Abstract][Full Text] [Related]
13. Surfactant protein-D is more useful than Krebs von den Lungen 6 as a marker for the early diagnosis of interstitial pneumonitis during pegylated interferon treatment for chronic hepatitis C.
Ishikawa T; Kubota T; Abe H; Hirose K; Nagashima A; Togashi T; Seki K; Honma T; Yoshida T; Kamimura T
Hepatogastroenterology; 2012 Oct; 59(119):2260-3. PubMed ID: 23435141
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate-induced acute lung injury in a patient with rheumatoid arthritis.
Taniguchi K; Usui Y; Matsuda T; Suzuki S; Fujiki K; Yakusiji F; Tomiyama J; Kinoshita K; Ilzuka H; Kuga Y
Int J Clin Pharmacol Res; 2005; 25(3):101-5. PubMed ID: 16366417
[TBL] [Abstract][Full Text] [Related]
15. [Two fatal cases of methotrexate-induced interstitial pneumonitis].
Matsushima H; Takayanagi N; Kawata I; Sakamoto T; Motegi M; Ubukata M; Yanagisawa T; Sugita Y; Kanazawa M; Kawabata Y
Nihon Kokyuki Gakkai Zasshi; 2002 Mar; 40(3):249-55. PubMed ID: 11974902
[TBL] [Abstract][Full Text] [Related]
16. KL-6: a serum marker for interstitial pneumonia.
Kobayashi J; Kitamura S
Chest; 1995 Aug; 108(2):311-5. PubMed ID: 7634858
[TBL] [Abstract][Full Text] [Related]
17. KL-6 and surfactant proteins A and D in serum and bronchoalveolar lavage fluid in patients with acute eosinophilic pneumonia.
Daimon T; Tajima S; Oshikawa K; Bando M; Ohno S; Sugiyama Y
Intern Med; 2005 Aug; 44(8):811-7. PubMed ID: 16157978
[TBL] [Abstract][Full Text] [Related]
18. A case of Wilson-Mikity syndrome with high serum KL-6 levels.
Takami T; Kumada A; Takei Y; Miyajima T; Hoshika A
J Perinatol; 2003 Jan; 23(1):56-8. PubMed ID: 12556928
[TBL] [Abstract][Full Text] [Related]
19. [Methotrexate pneumonitis].
Zingg K; Grossenbacher M; Conen D; Truninger K
Praxis (Bern 1994); 1999 Mar; 88(13):573-8. PubMed ID: 10235032
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of serum surfactant protein-D and KL-6 concentrations in patients with systemic sclerosis as markers for monitoring the activity of pulmonary fibrosis.
Yanaba K; Hasegawa M; Takehara K; Sato S
J Rheumatol; 2004 Jun; 31(6):1112-20. PubMed ID: 15170923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
